---
$id: https://graph.org.ai/products/commodity/51273004
$type: Product
source: UNSPSC
code: "51273004"
title: "Levoxadrol"
class: "51273000"
classTitle: "Anaesthetic piperidines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levoxadrol

**UNSPSC Code**: 51273004
**Class**: [Anaesthetic piperidines](Anaesthetic piperidines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an analgesic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 811X558HU0. European Medicines Agency schedules Levoxadrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08496MIG. Levoxadrol generally arises in the molecular formula C20H23NO2. The term LEVOXADROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) LEVOXADROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levoxadrol under HS 29349990 and SITC 51579. As of Q4 2014, LEVOXADROL remains the US FDA Preferred Term for this commodity. Levoxadrol bears US NLM identifiers UMLS ID C0125663 and NCI Concept Code C66010. SMILES: O1C(C2(NCCCC2)C)(COC1(C1CCCCC1)C1CCCCC1)C.

